Freek W.A. Verheugt - Concepedia

Author

Freek W.A. Verheugt

Also Known As

F VERHEUGT, F Verheugt, F W Verheugt, F. W. A. VERHEUGT, F. W. A. Verheugt, F. W.A. Verheugt, F.W.A Verheugt, F.W.A. Verheugt, FREEK W. A. Verheugt, Frans van de Werf

114

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center University of Amsterdam Erasmus MC Isala

About

Freek W.A. Verheugt is an author at Radboud University Nijmegen specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	23	1.3K
2	Public Health	8	8	168
3	Engineering	1	1	71
4	Biostatistics	1	1	21
5	Cardiothoracic Surgery	1	1	21

Freek W.A. Verheugt

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Predictors of Coronary Stent Thrombosis Jochem W. van Werkum, Antonius A.C.M. Heestermans, Anoek Zomer, Journal of the American College of Cardiology	2009	685
Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands Maarten L. Simoons, Jeroen Vos, Jan G.P. Tijssen, Journal of the American College of Cardiology ThrombosisCardiovascular DiseaseLong-term BenefitEarly Thrombolytic TherapyMedicine	1989	220
Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor A. van Vliet, A. J. M. Donker, Jos J. P. Nauta, The American Journal of Cardiology HypertensionHeart FailureCardiovascular DiseaseMedicineAntihypertensive Therapy	1993	171
Long-Term Clinical Outcome After a First Angiographically Confirmed Coronary Stent Thrombosis Jochem W. van Werkum, Antonius A.C.M. Heestermans, Fleur I. de Korte, Circulation	2009	164
Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty Lambert F.M van den Merkhof, Felix Zijlstra, Hans Olsson, Journal of the American College of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseAcute Myocardial InfarctionMedicineCardiology	1999	138
Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography C. M. C. van Campen, Freek W.A. Verheugt, Peter C. Rowe, Clinical Neurophysiology Practice	2020	135
Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute st elevation myocardial infarction Felix Zijlstra, Nicolette Ernst, Menko‐Jan de Boer, Journal of the American College of Cardiology ThrombosisInfarct-related ArteryCardiovascular DiseasePrehospital AdministrationInitial Patency	2002	131
Right ventricle Tei-index: A tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases M.J. Vonk, Mikael Sander, Fhj Vandenhoogen, European Journal of Echocardiography	2006	106
Diaphragm single-fiber weakness and loss of myosin in congestive heart failure rats Hieronymus W. H. van Hees, Coen A. C. Ottenheijm, Leo Heunks, American Journal of Physiology-Heart and Circulatory Physiology	2007	78
Effects of early intervention with low-dose aspirin (100 mg) on infarct size, reinfarction and mortality in anterior wall acute myocardial infarction Freek W.A. Verheugt, Arnoud van der Laarse, Albert J. Funke-Küpper, The American Journal of Cardiology ThrombosisCardiovascular DiseaseMedicineCoronary Artery DiseaseLow-dose Aspirin	1990	73

Page 1